SG Americas Securities LLC bought a new stake in Teleflex Incorporated (NYSE:TFX – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 9,886 shares of the medical technology company’s stock, valued at approximately $1,366,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Vontobel Holding Ltd. grew its position in shares of Teleflex by 21.9% in the fourth quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock valued at $248,000 after purchasing an additional 250 shares during the last quarter. Asset Management One Co. Ltd. grew its position in shares of Teleflex by 15.6% in the fourth quarter. Asset Management One Co. Ltd. now owns 19,233 shares of the medical technology company’s stock valued at $3,453,000 after purchasing an additional 2,589 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Teleflex in the fourth quarter valued at approximately $10,342,000. IFP Advisors Inc grew its position in shares of Teleflex by 238.5% in the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock valued at $55,000 after purchasing an additional 217 shares during the last quarter. Finally, Ameriprise Financial Inc. grew its position in shares of Teleflex by 62.4% in the fourth quarter. Ameriprise Financial Inc. now owns 23,660 shares of the medical technology company’s stock valued at $4,211,000 after purchasing an additional 9,094 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.
Wall Street Analysts Forecast Growth
TFX has been the topic of several research reports. Piper Sandler reaffirmed a “neutral” rating and issued a $140.00 target price (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Raymond James downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 27th. Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 28th. Finally, Bank of America downgraded Teleflex from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $164.63.
Teleflex Trading Up 1.0%
Shares of TFX stock opened at $121.09 on Tuesday. The stock’s fifty day moving average price is $126.61 and its two-hundred day moving average price is $151.62. The company has a market cap of $5.35 billion, a PE ratio of 24.07, a P/E/G ratio of 1.73 and a beta of 1.10. Teleflex Incorporated has a fifty-two week low of $118.70 and a fifty-two week high of $249.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.
Teleflex (NYSE:TFX – Get Free Report) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company’s revenue was down 5.0% compared to the same quarter last year. During the same quarter last year, the business posted $3.21 EPS. Equities analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Investors of record on Tuesday, May 20th were given a dividend of $0.34 per share. The ex-dividend date was Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a yield of 1.12%. Teleflex’s dividend payout ratio is currently 42.90%.
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Further Reading
- Five stocks we like better than Teleflex
- How to Capture the Benefits of Dividend Increases
- New Catalysts to Drive NVIDIA’s Stock Price Even Higher
- Insider Trading – What You Need to Know
- China Market Movers: MCHI, PDD, BIDU Show Bullish Trends
- What does consumer price index measure?
- Palantir Defies Bears, Leads S&P 500 in 2025
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.